BEIJING—China has demonstrated it can weaponize its control over global supply chains by constricting the flow of critical rare-earth minerals. President Trump went to the negotiating table when…
Read more How China’s Chokehold on Drugs, Chips and More Threatens the U.S.For years, the U.S. and China have been locked in a pattern on the deadly issue of fentanyl. The White House pressures Beijing to stop Chinese companies from…
Read more Trump Says Xi Will Help Fight Fentanyl. Will China Follow Through?In March, Sen. Steve Daines traveled to Beijing with a group of American chief executives in hopes of calming a tense trade relationship between the world’s two largest…
Read more The Long Road to a U.S.-China Trade PactPresident Trump’s vow to intervene against drug smugglers in Colombia widened a U.S. counternarcotics campaign in Latin America that began with military strikes on oceangoing boats but is…
Read more Trump Turns Up Heat on Latin AmericaPresident Trump said the U.S. would stop aid payments to Colombia, for decades a close U.S. ally, because of the country’s drug production. Trump, in a social-media post…
Read more Trump Says U.S. Is Cutting Aid to Colombia Over DrugsDayforce, Scholar Rock, and More Stocks See Action From Activist Investors Source link
Read more Dayforce, Scholar Rock, and More Stocks See Action From Activist InvestorsNew York Bio Connect, a new health and life sciences hub, has officially launched to serve as a central resource for New York’s life science community. Designed to…
Read more Life sciences advocates, economic development agencies launch centralized hub | Long Island Business NewsSia/LBG has been awarded a supplemental grant by the Gates Foundation to enhance its web-based cost and environmental impact modeling resource for pharmaceutical APIs Cost of Goods (COGs).…
Read more Sia/LBG Receives Supplemental Grant to Expand Features for Global Health Cost Model PlatformOn Aug. 13, Middlesex Community College’s biotechnology program received a Pathmaker Validation from the Mass Life Sciences Center. Representatives from MLSC joined Middlesex President Phil Sisson, Provost Arlene…
Read more MCC’s biotechnology program receives Pathmaker Validation from Mass Life Sciences CenterCorrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections & Amplifications This headline was corrected…
Read more GSK PLC 4Q Pre-items, Pretax Pft GBP1.56BBy Andrea Figueras Roche said that the European Commission approved Tecentriq SC, a cancer immunotherapy subcutaneous injection for multiple cancer types. The Swiss pharmaceutical company said Tuesday that…
Read more Roche's Cancer Injection Tecentriq SC Gets European Commission ApprovalShares of Medical Properties Trust plummeted after the real estate investment trust said it is ramping up efforts to recover uncollected rent and outstanding loans from its largest…
Read more Medical Properties Trust Stock Is CrashingThe Russell 2000 Index soared 12% in December, which might reflect investors’ exuberance about the state of the U.S. economy — it appears the Federal Reserve has won…
Read more The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks(Updated with Friday’s closing prices.) The 2023 rally for stocks in the U.S. accelerated as more investors bought the idea that the Federal Reserve succeeded in its effort…
Read more These 20 stocks soared the most in 2023Updated Dec 27, 2023, 7:34 am EST / Original Dec 27, 2023, 4:26 am EST Stock futures traded slightly lower Wednesday after the S&P 500 finished higher Tuesday and…
Read more Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market MoversBristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription. View Options Source link
Read more Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 BillionTwo weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly 100,000 people in…
Read more Bluebird Bio Stock Is in Free FallDec 19, 2023, 4:31 am EST Stock futures traded flat Tuesday, a day after the S&P 500 finished up 0.5% and moved closer to its all-time. The broad…
Read more Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market MoversSmileDirectClub Inc. said late Friday it was winding down operations, effective immediately, seeming to cast its millions of customers adrift — except when it comes to their bills.…
Read more SmileDirectClub winds down operations — but customers are told to keep payingBy Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The Swiss pharmaceutical company said Tuesday…
Read more Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study
